ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder

ClinicalTrials.gov ID: NCT02741791

Public ClinicalTrials.gov record NCT02741791. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 6:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

STRIDE-1: A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects With Treatment Resistant Major Depressive Disorder

Study identification

NCT ID
NCT02741791
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
312 participants

Conditions and interventions

Interventions

  • AXS-05 Drug
  • Bupropion Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2016
Primary completion
Mar 19, 2020
Completion
Mar 19, 2020
Last update posted
Mar 23, 2021

2016 – 2020

United States locations

U.S. sites
74
U.S. states
32
U.S. cities
74
Facility City State ZIP Site status
Not listed Phoenix Arizona
Not listed Little Rock Arkansas
Not listed Anaheim California
Not listed Beverly Hills California
Not listed Garden Grove California
Not listed Oakland California
Not listed Oceanside California
Not listed Panorama City California
Not listed Redlands California
Not listed Riverside California
Not listed San Diego California
Not listed San Francisco California
Not listed Sherman Oaks California
Not listed Temecula California
Not listed Upland California
Not listed Colorado Springs Colorado
Not listed Cromwell Connecticut
Not listed Washington D.C. District of Columbia 20016
Not listed Coral Springs Florida
Not listed Fort Lauderdale Florida
Not listed Fort Myers Florida
Not listed Gainesville Florida
Not listed Jacksonville Florida 32256
Not listed Lakeland Florida
Not listed North Miami Florida
Not listed Orlando Florida
Not listed Pensacola Florida
Not listed St. Petersburg Florida
Not listed Atlanta Georgia 30328
Not listed Boise Idaho
Not listed Skokie Illinois
Not listed Shreveport Louisiana
Not listed Baltimore Maryland
Not listed Saint Charles Missouri
Not listed St Louis Missouri
Not listed Lincoln Nebraska
Not listed Las Vegas Nevada
Not listed Nashua New Hampshire
Not listed Berlin New Jersey
Not listed Cherry Hill New Jersey
Not listed Marlton New Jersey
Not listed Princeton New Jersey
Not listed Toms River New Jersey
Not listed Albuquerque New Mexico
Not listed Brooklyn New York
Not listed Jamaica New York 11432
Not listed New York New York
Not listed Rochester New York
Not listed Staten Island New York
Not listed Charlotte North Carolina
Not listed Canton Ohio
Not listed Dayton Ohio
Not listed Middleburg Heights Ohio
Not listed Oklahoma City Oklahoma
Not listed Portland Oregon
Not listed Salem Oregon
Not listed Allentown Pennsylvania
Not listed Media Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Lincoln Rhode Island
Not listed Charleston South Carolina
Not listed Memphis Tennessee 38119
Not listed Austin Texas
Not listed Dallas Texas
Not listed Houston Texas
Not listed San Antonio Texas
Not listed Wichita Falls Texas
Not listed Orem Utah
Not listed Charlottesville Virginia
Not listed Herndon Virginia
Not listed Bellevue Washington
Not listed Seattle Washington
Not listed Spokane Washington
Not listed Waukesha Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02741791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2021 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02741791 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →